wyszukanych pozycji: 5
Improving the Regulatory Review Process: Assessing Performance and Setting Targets
ISBN: 9789401060424 / Angielski / Miękka / 2012 / 163 str. Termin realizacji zamówienia: ok. 20 dni roboczych. At a time when it is becoming usual for medicines to be developed for a global market and pharmaceutical companies are endeavouring to expedite the drug development process, Regulatory Authorities are concentrating on improving their efficiency and effectiveness. Therefore, it is not surprising that questions are being asked as to how performance might be measured and compared between different authorities who are now often in receipt of dossiers that have been submitted to several agencies at the same time. Issues such as 'what target should be set for the review of new medicines?' and how...
At a time when it is becoming usual for medicines to be developed for a global market and pharmaceutical companies are endeavouring to expedite the dr...
|
|
cena:
194,52 zł |
The Relevance of Ethnic Factors in the Clinical Evaluation of Medicines: Proceedings of a Workshop held at The Medical Society of London, UK, 7th and 8th July, 1993
ISBN: 9789401046213 / Angielski / Miękka / 2012 / 262 str. Termin realizacji zamówienia: ok. 20 dni roboczych. For a research-based pharmaceutical company to be successful in the 1990s. it must have a strategic plan for the global development of new chemical entities. Global development can be defined as an attempt to reach all major markets as rapidly as possible and for many companies these will include the United States. Japan. Germany. France. Italy. UK and Canada. which together represent approximately 85% of the pharmaceutical market in the developed world. The mutual acceptance of foreign clinical data would reduce the time and resources required to develop a new medicine for the international...
For a research-based pharmaceutical company to be successful in the 1990s. it must have a strategic plan for the global development of new chemical en...
|
|
cena:
194,52 zł |
The Timing of Toxicological Studies to Support Clinical Trials
ISBN: 9789401046237 / Angielski / Miękka / 2012 / 150 str. Termin realizacji zamówienia: ok. 20 dni roboczych. Over the past twelve years, the Centre for Medicines Research has held a series of Workshops on a number of topics related to the drug discovery and development process. The major objective of these Workshops has been to provide an international forum for regula tory, academic and industry representatives to debate together, and suggest solutions to, specific problems. The meeting reported in this volume represents a departure from this approach, in that the par ticipants were drawn largely from the pharmaceutical industry. Senior clinicians, pharmacologists and toxicologists from companies...
Over the past twelve years, the Centre for Medicines Research has held a series of Workshops on a number of topics related to the drug discovery and d...
|
|
cena:
389,09 zł |
The Relevance of Ethnic Factors in the Clinical Evaluation of Medicines: Medicines
ISBN: 9780792388432 / Angielski / Twarda / 1994 / 262 str. Termin realizacji zamówienia: ok. 13-18 dni roboczych. There is currently limited acceptance of foreign clinical data by regulatory authorities, although the reasons for repeating studies are poorly defined. There are some proven genetic differences in drug metabolism and elimination which occur with varying frequencies in different populations. In addition, there are differences in culture, environment and medical practice which can impact on drug reponsiveness.
There is currently limited acceptance of foreign clinical data by regulatory authorities, although the reasons for repeating studies are poorly define...
|
|
cena:
534,39 zł |
Improving the Regulatory Review Process: Assessing Performance and Setting Targets
ISBN: 9780792387312 / Angielski / Twarda / 1998 / 163 str. Termin realizacji zamówienia: ok. 13-18 dni roboczych. At a time when it is becoming usual for medicines to be developed for a global market and pharmaceutical companies are endeavouring to expedite the drug development process, Regulatory authorities are concentrating on improving their efficiency and effectiveness. Therefore, it is not surprising that questions are being asked as to how performance might be measured and compared between different authorities who are now often in receipt of dossiers that have been submitted to several agencies at the same time. Issues such as what target should be set for the review of new medicines? and how can...
At a time when it is becoming usual for medicines to be developed for a global market and pharmaceutical companies are endeavouring to expedite the dr...
|
|
cena:
534,39 zł |